BSE · 524238
Gujarat Inject Kerala Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹19 Cr with net profit ₹1 Cr — a 5.29% net margin, versus 1.41% the period before.
Shareholding
As of 2026-06-30
- Public100%
8,038 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
Not enough history.
52-week position
Where the current price sits in its yearly band
The band spans 13.47× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
- 52-week range spans 13.47× (₹10.2 to ₹137.35) — an unusually wide band.
Peer comparison
Trading · ranked #172 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,96,659 Cr | 24.35 | 4.87 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,52,648 Cr | 383.94 | 10.32 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,59,927 Cr | 92.65 | 22.9 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹95,580 Cr | 1236.11 | 66.46 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,539 Cr | 56.78 | 6.81 | 11.32% | 6.61% |
| Premier Energies Limited | ₹44,610 Cr | 29.55 | 10.36 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹43,850 Cr | 106.87 | 7.24 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹38,417 Cr | 226.85 | 20.46 | 19.61% | 8.72% |
| Redington Limited | ₹24,309 Cr | 15.27 | 2.39 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,510 Cr | 209.37 | 10.28 | 14.16% | 8.36% |
| Gujarat Inject Kerala Limited(this company) | ₹149 Cr | 51 | 12.62 | 15.34% | 6.47% |
AI analysis
AI-generated · google/gemini-2.5-flashGujarat Inject Kerala Limited is listed with a market capitalization of Rs 186 Cr. The company reported revenue of Rs 19.23 Cr and a profit margin of 6.47%. Earnings per share (EPS) stood at 0.2, with a return on equity (ROE) of 15.34% and return on capital employed (ROCE) of 21.1694%.
Positives
- +The company has a debt-to-equity ratio of 0, indicating no debt.
- +Return on capital employed (ROCE) is 21.1694% for the latest reported period.
- +The company's net profit improved from a negative Rs 0.1052484 Cr in Mar 2021 to a positive Rs 1.017184 Cr in Mar 2025.
Negatives
- −The promoter holding is 0% as of Mar 2026.
- −The company is under ESM 1 surveillance.
- −Revenue growth for the latest period is not available in the provided data.
- −Quarterly EPS figures are missing for all reported quarters.
- −The dividend yield is 0%.
Financial Performance
The company's revenue increased significantly from Rs 0.01975 Cr in Mar 2021 to Rs 19.2261588 Cr in Mar 2025. Net profit also showed recovery and growth, moving from a negative Rs 0.1052484 Cr in Mar 2021 to a positive Rs 1.017184 Cr in Mar 2025. Earnings per share (EPS) improved from -0.12 in Mar 2021 to 1.13 in Mar 2025.
Profitability & Returns
Gujarat Inject Kerala Limited reported a profit margin of 6.47%. The return on equity (ROE) for the latest period was 15.34%, and the return on capital employed (ROCE) was 21.1694%. The company's PE ratio is 63.5, and book value stands at 0.81.
Balance Sheet
The company maintains a debt-to-equity ratio of 0, indicating no debt. The book value per share is 0.81. No information regarding dividend yield is available in the provided data.
Ownership & Pledges
As of Mar 2026, public shareholding in Gujarat Inject Kerala Limited stands at 100%, with no promoter or institutional holding. There are no reported promoter pledges. The total number of shareholders was 7853 as of Mar 2026.
Regulatory & Surveillance
Gujarat Inject Kerala Limited is currently under ESM (Enhanced Surveillance Measure), specifically 'ESM 1', according to the 'surveillance' data. This indicates specific regulatory scrutiny or monitoring.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Gujarat Inject Kerala Limitedshare price & fundamentals